4//SEC Filing
CELGENE CORP /DE/ 4
Accession 0001209191-15-005044
CIK 0000816284operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:11 PM ET
Size
9.8 KB
Accession
0001209191-15-005044
Insider Transaction Report
Form 4
STEIN LAWRENCE V
See Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-01-15−24,124→ 48,250 totalExercise: $39.33Exp: 2022-12-03→ Common Stock (24,124 underlying) - Sale
Common Stock
2015-01-15$120.01/sh−26,666$3,200,253→ 4,192 total - Exercise/Conversion
Common Stock
2015-01-15$39.33/sh+24,124$948,797→ 30,858 total
Holdings
- 341(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The price report in Column 4 is a weighted average price. These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan in multiple transactions at prices ranging from $118.62 to $122.41, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The option was fully exercisable.
- [F3]The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (amended and restated as of April 17, 2013).
Documents
Issuer
CELGENE CORP /DE/
CIK 0000816284
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000816284
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:11 PM ET
- Size
- 9.8 KB